Table 1.
Characteristics of case 1
| Characteristics of 1 | Leakage (n = 5) | No leakage (n = 45) |
|---|---|---|
| Sex | ||
| Male | 4 | 35 |
| Female | 1 | 10 |
| Mean age | 68(51–82) | |
| Tumor location | ||
| Cervical | 0 | 0 |
| Upper thoracic | 0 | 2 |
| Middle thoracic | 5 | 18 |
| Lower thoracic | 0 | 21 |
| Esophagogastric junction | 0 | 4 |
| Characteristics of case 2 | |||
|---|---|---|---|
| Characteristic 2 | Leakage (n = 5) | No leakage (n = 45) | p values |
| Neoadjuvant chemotherapy | |||
|
Docetaxel + cisplatin + 5-fluorouracil |
3 | 27 | p = 0.63 |
| Cisplatin + 5-fluorouracil | 1 | 7 | p = 0.69 |
| Others | 0 | 4 | p = 0.86 |
| None | 1 | 7 | p = 0.71 |
| Reconstruction route | |||
| Retrosternal | 4 | 43 | p = 0.18 |
| Posterior mediastinum | 1 | 2 | |
| Preoperative hemoglobin* | 10.9 | 11.4 | p = 0.57 |
| Volume of blood loss* | 363 | 261 | p = 0.41 |
| Albumin* | 3.7 | 3.8 | p = 0.76 |
| Glycated hemoglobin* | 5.9 | 5.7 | p = 0.58 |
| Brinkman Index* | 370 | 513 | p = 0.45 |